IMMUNE OS ATLASby AllerimSign in

cell

CD8 Cytotoxic T Cell

Antigen-specific killing cell for viral control, tumor surveillance, memory, and exhaustion biology

CD8cytotoxicviralcancer

Review layer

Last reviewed 2026-05-17

conceptualeducational

Systems teaching draft. Content is structured for education and graph expansion, with formal source tagging ready for the next review pass.

Provenance layer

External context

static reviewed map

Curated external IDs add pathway and protein context around Atlas content. They do not update the graph automatically and they are not patient-specific interpretation.

State signature

Systems profile

Inflammation52
Tolerance45
Metabolism54
Tissue62
Neuroimmune38
Chronicity78

System effects

Primary mapped axes from existing Atlas data.

Interpretive

Chronicity

High 78

Memory, priming, fibrosis, exhaustion, remodeling, or other time-dependent drift.

Effector killingMemory selectionExhaustion adaptation

Tissue

Moderate 62

Organ, barrier, stromal, vascular, or local niche behavior.

GutLungSkinCNS

Metabolism

Light 54

Energy allocation, glycolysis, mitochondrial strain, lipid signaling, or nutrient-sensitive behavior.

glycolytic effector expansionmitochondrial memory fitnessnutrient competition in tumors

Local map

Relationship field

Arrows point from the upstream source toward the receiving target. Restraint edges use a bar; association edges stay dashed because they are not causal arrows.

CD8 Cytotoxic T Cell
IFN-gammaAntiviral / Interferon Pattern

Selected relationship

Release / output

Cytotoxic T cells produce IFN-gamma during antiviral and tumor responses

Read as source produces or releases the target signal.

What this relationship means

Read this as output: CD8 Cytotoxic T Cell can release IFN-gamma, which then carries the next part of the signal.

Effect of source

CD8 Cytotoxic T Cell is the producing cell or node.

Effect on target

IFN-gamma is the released mediator to follow downstream.

Use with caution

Release edges show possible biology, not measured patient levels.

System effect

CD8 Cytotoxic T Cell releases IFN-gamma; the mapped axes are inherited mainly from the released signal.

Release output

Inflammation

Light 52

Inflammatory alarm, recruitment, mediator release, or tissue-damaging amplification.

TH1macrophage+18 more

Tissue

Moderate 62

Organ, barrier, stromal, vascular, or local niche behavior.

MHC upregulationgranuloma support+12 more

Metabolism

Light 54

Energy allocation, glycolysis, mitochondrial strain, lipid signaling, or nutrient-sensitive behavior.

pushes macrophages toward inflammatory ...glycolytic effector expansion+2 more

Axes are mapped cues from Atlas data, not clinical predictions.

Evidence context

Curated edge, reviewed endpoints, and mapped external anchors.

Atlas edge
CD8 Cytotoxic T Cell - reviewed 2026-05-17 - conceptualIFN-gamma - reviewed 2026-05-17 - conceptual3 external anchors
Reactomehigh+2 more

Interferon gamma signaling

R-HSA-877300 - checked 2026-06-28

Graph neighborhood

Direct relationships

Full graph

Arrow shows upstream source toward receiving target.

Cytotoxic T cells produce IFN-gamma during antiviral and tumor responses

Context link: no causal arrow.

CD8 T cells execute cytotoxic containment and can enter exhaustion under chronic antigen load

Network behavior

Systems Overview

CD8 T cells recognize peptide-MHC I and kill infected or transformed cells through perforin, granzymes, cytokines, and death-receptor pathways.

Lineage

Origin

HSC -> lymphoid progenitor -> thymocyte -> CD8 T cell -> effector, memory, tissue-resident, or exhausted CD8 state

Transcription factors: T-bet, Eomes, RUNX3, TCF1, TOX

Lifecycle Visualizer

days

Priming

Antigen and costimulation

MHC ICD28type I IFN

days-weeks

Effector killing

Cytotoxic expansion

perforingranzyme B

weeks

Memory selection

Long-lived recall pool

IL-7IL-15

weeks-years

Exhaustion adaptation

Chronic antigen restraint

PD-1TOX

Activation and Suppression

Activators

peptide-MHC ICD28 costimulationIL-2IL-12type I interferonsIL-15

Suppressors

PD-1 ligandsTregsTGF-betaIL-10adenosinetumor metabolic restriction

Surface and Secreted Signals

Surface markers

CD3CD8TCRMHC I restrictionNKG2DPD-1CD45RA/RO

Secretions

IFN-gammaTNF-alphagranzyme BperforinCCL5

Metabolic State

Programs

glycolytic effector expansionmitochondrial memory fitnessnutrient competition in tumors

Acute: Effector CD8 cells expand rapidly and kill target cells.

Chronic: Persistent antigen drives checkpoint expression, TOX programs, mitochondrial strain, and exhaustion.

Tissue Roles

gut: Viral and intracellular pathogen defense with tissue injury risk.

lung: Respiratory viral clearance and resident memory.

skin: Resident memory and cytotoxic autoimmune dermatitis patterns.

CNS: Can control infection but also contribute to neuroinflammatory injury.

lymphoid: Priming and memory selection.

Disease Associations

viral infectioncancerautoimmunitytransplant rejectionT cell exhaustion

Clinical Pearls

  • CD8 cells are the core antigen-specific killing layer.
  • Checkpoint expression can mean active adaptation to chronic antigen, not simply failure.
  • Tumors often suppress CD8 function through antigen loss, checkpoints, Tregs, and nutrient competition.